CHICAGO — In this Healio Video Perspective from the AAO meeting, I. Paul Singh, MD, shares data about the Glaukos iStent infinite, designed to reduce IOP.
“Placing three iStents into the nasal angle 2 clock hours apart from each other, we found that we actually got 76% of patients with a 20% reduction of intraocular pressure with the same or less meds, an average about a 13% less medication burden,” Singh said. “Having access to these stents in a stand-alone population will change the paradigm over time.”